Red Light Holland (TSE:TRIP) has released an update.
Red Light Holland has successfully completed a crucial psilocybin extraction process with PharmAla Biotech, creating a high-quality, concentrated psilocybin extract from its Netherlands-sourced truffles. The milestone is a testament to the company’s capability and is foundational for future development phases. CEO Todd Shapiro hailed the achievement as key to optimizing the production of natural-source psilocybin for pharmaceutical use.
For further insights into TSE:TRIP stock, check out TipRanks’ Stock Analysis page.
